ASBMB offers feedback on NIH’s proposed grant review framework
After soliciting feedback from its members, the American Society for Biochemistry and Molecular Biology sent nine recommendations to the National Institutes of Health last week related to proposed changes to the research grant application peer-review process.
The society’s March 1 letter suggested:
Validating the proposed framework with a pilot study
Revamping the study section grant triage process
Conducting outreach before and during implementation
Using alternative criteria for certain types of projects
Moving forward with simplifying scored criteria and administrative document review
The NIH Office of Extramural Research published a request for information on Dec. 7 seeking public input on a proposed revised framework by the Center for Scientific Review for evaluating and scoring of peer-reviewed research project grant applications.
The proposed framework reduces the number of categories reviewers must evaluate and asks that reviewers focus on two major questions: “Should it be done?” and “Can it be done well?” In addition, the framework proposes removing individual scoring for the investigator and environment. Instead, reviewers would qualitatively evaluate and rate an applicant’s expertise and resources with the goal of reducing bias in peer review. Finally, study section volunteers would review less material from the “Additional Review Considerations” section of the application.
The goal of the revised framework is two-fold. First, the NIH seeks to reduce the emphasis on investigator reputation during grant review. Second, the NIH seeks to reduce the administrative burden on study section members.
The ASBMB was compelled to respond because the society is composed of predominately NIH-funded investigators, many of whom serve on study sections.
“Since the majority of our members will be directly affected by any changes to NIH grant review processes, we felt it was our responsibility to make sure their voices are heard as well as support their continued success in receiving federal funding,” Sarina Neote, director of public affairs at the ASBMB, said. “In addition, since part of our mission is advocating for underrepresented groups, we want to ensure that these proposed changes are making the review process more equitable for researchers at all levels.”
Although the ASBMB expressed support for NIH’s efforts to simplify and make peer review less biased, Neote said, the society wants to ensure the proposed changes also accomplish NIH’s goals.
In its comment letter to CSR, the society wrote: “To validate that the proposed framework reduces reputational bias and ensure that the proposed changes are data-driven, the ASBMB asks CSR to conduct a thorough pilot study of the proposed framework across all research project grants.”
During study section, only the preliminarily top scoring grants are discussed. This process leaves all borderline and low-scoring grants behind, known as triage. Every study section member has the opportunity to bring forward a triaged proposal that may have received a borderline score due to receiving two outstanding and one low, outlier score. However, this rarely occurs. Therefore, the ASBMB recommended revamping the triage process to build in time for study section discussion of borderline-scoring applications.
“This goal could be accomplished in two ways: First, task the scientific review officer with initiating discussion of borderline-scoring proposals and/or second, automatically include a set time for discussion of these proposals,” the ASBMB wrote. “The ASBMB urges CSR to ensure that quality scientific research projects are not left behind during the triage process.”
Because the current framework has been in place for decades, the ASBMB asserted that substantial outreach and education will be needed to ensure a seamless transition to the new framework. The society called upon NIH to make educational resources such as toolkits broadly available, not only to high-research-activity institutions but to emerging and minority-serving institutions as well.
The society also expressed concern about using the proposed framework to evaluate all research grants, in particular R15 awards. According to the NIH, R15 awards are research enhancements that are designed to support “small-scale research projects at educational institutions that provide baccalaureate or advanced degrees for a significant number of the nation’s research scientists but that have not been major recipients of NIH support.”
The society wrote: “Although R15s are similar to other research grants that fund meritorious research projects, the mechanisms of scope and feasibility can vary depending on the capacity of the institution. … (T)he smaller scope of work that is feasible at primarily undergraduate institutions may be disadvantaged under the new framework in comparison with larger labs that host undergraduate research.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.Learn more
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Policy
Policy highlights or most popular articles
'I hope that our actions show our members that we are doing our best to support them'
A Q&A with ASBMB Policy Manager Raechel McKinley on the organization’s national-level advocacy for LGBTQIA+ scientists, trainees and students.
State laws change the landscape for LGBTQIA+ scientists
New legislation in the past 16 months has banned gender affirming care for transgender teens, teaching children about sexual orientation and gender identity, and drag shows.
Meet the 2023 ASBMB Advocacy Training Program delegates
ASBMB announces a new cohort of 12 ASBMB Advocacy Training Program delegates who will learn about science policy and advocacy through this summer externship
ASBMB members meet with lawmakers on the Hill
In 48 meetings, scientists advocated for budget increases for NIH, NSF and DOE.
Researchers to advocate for fundamental science on Capitol Hill
Sixteen ASBMB researchers from 16 states to meet with U.S. senators and representatives on Capitol Hill to advocate for basic science research funding for NIH, NSF, DOE
Will new FDA rules help dial back expedited drugs?
Recent reforms could require companies to perform follow-up studies on drugs that received accelerated approval.